Loading...
Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Revere Kinkel

    TitleProfessor Of Clinical
    SchoolUniversity of California, San Diego
    DepartmentNeurosciences
    Address200 W. Arbor Drive #8687
    CA San Diego 92103
    Phone619-543-3500
    vCardDownload vCard

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Louapre C, Govindarajan ST, Giannì C, Madigan N, Sloane JA, Treaba CA, Herranz E, Kinkel R, Mainero C. Heterogeneous pathological processes account for thalamic degeneration in multiple sclerosis: Insights from 7?T imaging. Mult Scler. 2017 Aug 01; 1352458517726382. PMID: 28803512.
        View in: PubMed
      2. Louapre C, Govindarajan ST, Giannì C, Madigan N, Nielsen AS, Sloane JA, Kinkel R, Mainero C. The association between intra- and juxta-cortical pathology and cognitive impairment in multiple sclerosis by quantitative T2* mapping at 7 T MRI. Neuroimage Clin. 2016; 12:879-886. PMID: 27872810.
        View in: PubMed
      3. Herranz E, Giannì C, Louapre C, Treaba CA, Govindarajan ST, Ouellette R, Loggia ML, Sloane JA, Madigan N, Izquierdo-Garcia D, Ward N, Mangeat G, Granberg T, Klawiter EC, Catana C, Hooker JM, Taylor N, Ionete C, Kinkel R, Mainero C. Neuroinflammatory component of gray matter pathology in multiple sclerosis. Ann Neurol. 2016 Nov; 80(5):776-790. PMID: 27686563.
        View in: PubMed
      4. Louapre C, Govindarajan ST, Giannì C, Langkammer C, Sloane JA, Kinkel R, Mainero C. Beyond focal cortical lesions in MS: An in vivo quantitative and spatial imaging study at 7T. Neurology. 2015 Nov 10; 85(19):1702-9. PMID: 26468411; PMCID: PMC4653110 [Available on 11/10/16].
      5. Louapre C, Govindarajan ST, Giannì C, Cohen-Adad J, Gregory MD, Nielsen AS, Madigan N, Sloane JA, Kinkel R, Mainero C. Is the Relationship between Cortical and White Matter Pathologic Changes in Multiple Sclerosis Spatially Specific? A Multimodal 7-T and 3-T MR Imaging Study with Surface and Tract-based Analysis. Radiology. 2016 Feb; 278(2):524-35. PMID: 26334679; PMCID: PMC4734161 [Available on 02/01/17].
      6. Sloane JA, Mainero C, Kinkel R. No Evidence of Disease Activity in Multiple Sclerosis. JAMA Neurol. 2015 Jul; 72(7):835-6. PMID: 26167901.
        View in: PubMed
      7. Mainero C, Louapre C, Govindarajan ST, Giannì C, Nielsen AS, Cohen-Adad J, Sloane J, Kinkel R. A gradient in cortical pathology in multiple sclerosis by in vivo quantitative 7 T imaging. Brain. 2015 Apr; 138(Pt 4):932-45. PMID: 25681411; PMCID: PMC4677339.
      8. Kinkel R, Laforet G, You X. Disease-related determinants of quality of life 10 years after clinically isolated syndrome. Int J MS Care. 2015 Jan-Feb; 17(1):26-34. PMID: 25741224; PMCID: PMC4338640.
      9. Fan AP, Govindarajan ST, Kinkel R, Madigan NK, Nielsen AS, Benner T, Tinelli E, Rosen BR, Adalsteinsson E, Mainero C. Quantitative oxygen extraction fraction from 7-Tesla MRI phase: reproducibility and application in multiple sclerosis. J Cereb Blood Flow Metab. 2015 Jan; 35(1):131-9. PMID: 25352043; PMCID: PMC4294406.
      10. Kinkel R, Simon JH, O'Connor P, Hyde R, Pace A. Early MRI activity predicts treatment nonresponse with intramuscular interferon beta-1a in clinically isolated syndrome. Mult Scler Relat Disord. 2014 Nov; 3(6):712-9. PMID: 25891550.
        View in: PubMed
      11. Chalkias S, Dang X, Bord E, Stein MC, Kinkel R, Sloane JA, Donnelly M, Ionete C, Houtchens MK, Buckle GJ, Batson S, Koralnik IJ. JC virus reactivation during prolonged natalizumab monotherapy for multiple sclerosis. Ann Neurol. 2014 Jun; 75(6):925-34. PMID: 24687904; PMCID: PMC4425205.
      12. Nielsen AS, Kinkel R, Madigan N, Tinelli E, Benner T, Mainero C. Contribution of cortical lesion subtypes at 7T MRI to physical and cognitive performance in MS. Neurology. 2013 Aug 13; 81(7):641-9. PMID: 23864311; PMCID: PMC3775688.
      13. Nielsen AS, Kinkel R, Tinelli E, Benner T, Cohen-Adad J, Mainero C. Focal cortical lesion detection in multiple sclerosis: 3 Tesla DIR versus 7 Tesla FLASH-T2. J Magn Reson Imaging. 2012 Mar; 35(3):537-42. PMID: 22045554; PMCID: PMC4198329.
      14. Kinkel R, Dontchev M, Kollman C, Skaramagas TT, O'Connor PW, Simon JH. Association between immediate initiation of intramuscular interferon beta-1a at the time of a clinically isolated syndrome and long-term outcomes: a 10-year follow-up of the Controlled High-Risk Avonex Multiple Sclerosis Prevention Study in Ongoing Neurological Surveillance. Arch Neurol. 2012 Feb; 69(2):183-90. PMID: 21987393.
        View in: PubMed
      15. Nielsen AS, Miravalle A, Langer-Gould A, Cooper J, Edwards KR, Kinkel R. Maximally tolerated versus minimally effective dose: the case of rituximab in multiple sclerosis. Mult Scler. 2012 Mar; 18(3):377-8. PMID: 21828201.
        View in: PubMed
      16. Nielsen AS, Halamka JD, Kinkel R. Internet portal use in an academic multiple sclerosis center. J Am Med Inform Assoc. 2012 Jan-Feb; 19(1):128-33. PMID: 21571744; PMCID: PMC3240754.
      17. Iezzoni LI, Rao SR, Kinkel R. Experiences acquiring and using mobility aids among working-age persons with multiple sclerosis living in communities in the United States. Am J Phys Med Rehabil. 2010 Dec; 89(12):1010-23. PMID: 20881588.
        View in: PubMed
      18. Miravalle A, Jensen R, Kinkel R. Immune reconstitution inflammatory syndrome in patients with multiple sclerosis following cessation of natalizumab therapy. Arch Neurol. 2011 Feb; 68(2):186-91. PMID: 20937940.
        View in: PubMed
      19. Chen Y, Bord E, Tompkins T, Miller J, Tan CS, Kinkel R, Stein MC, Viscidi RP, Ngo LH, Koralnik IJ. Asymptomatic reactivation of JC virus in patients treated with natalizumab. N Engl J Med. 2009 Sep 10; 361(11):1067-74. PMID: 19741227; PMCID: PMC3077718.
      20. Iezzoni LI, Rao SR, Kinkel R. Patterns of mobility aid use among working-age persons with multiple sclerosis living in the community in the United States. Disabil Health J. 2009 Apr; 2(2):67-76. PMID: 21122745.
        View in: PubMed
      21. Jensen RM, Kinkel R. Acute paraplegia with vanishing white matter lesions. Rev Neurol Dis. 2008; 5(3):159-60; discussion 164-6. PMID: 18838956.
        View in: PubMed
      22. Miller DM, Kinkel R. Health-related quality of life assessment in multiple sclerosis. Rev Neurol Dis. 2008; 5(2):56-64. PMID: 18660737.
        View in: PubMed
      23. Kinkel R. Interferon-beta1a: a once-weekly immunomodulatory treatment for patients with multiple sclerosis. Expert Rev Clin Immunol. 2006 Sep; 2(5):691-704. PMID: 20477625.
        View in: PubMed
      24. Kinkel R, Kollman C, O'Connor P, Murray TJ, Simon J, Arnold D, Bakshi R, Weinstock-Gutman B, Brod S, Cooper J, Duquette P, Eggenberger E, Felton W, Fox R, Freedman M, Galetta S, Goodman A, Guarnaccia J, Hashimoto S, Horowitz S, Javerbaum J, Kasper L, Kaufman M, Kerson L, Mass M, Rammohan K, Reiss M, Rolak L, Rose J, Scott T, Selhorst J, Shin R, Smith C, Stuart W, Thurston S, Wall M. IM interferon beta-1a delays definite multiple sclerosis 5 years after a first demyelinating event. Neurology. 2006 Mar 14; 66(5):678-84. PMID: 16436649.
        View in: PubMed
      25. Beck RW, Chandler DL, Cole SR, Simon JH, Jacobs LD, Kinkel R, Selhorst JB, Rose JW, Cooper JA, Rice G, Murray TJ, Sandrock AW. Interferon beta-1a for early multiple sclerosis: CHAMPS trial subgroup analyses. Ann Neurol. 2002 Apr; 51(4):481-90. PMID: 11921054.
        View in: PubMed